Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Should You Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBYGet Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $8.20 and last traded at $8.26, with a volume of 34265 shares changing hands. The stock had previously closed at $8.4250.

Analyst Ratings Changes

Separately, Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

View Our Latest Analysis on CLPBY

Coloplast A/S Stock Down 2.4%

The firm’s 50 day simple moving average is $8.71 and its 200 day simple moving average is $9.11. The company has a market cap of $18.53 billion, a price-to-earnings ratio of 34.25, a price-to-earnings-growth ratio of 0.83 and a beta of 0.26. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 1.20.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%. Sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

Featured Stories

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.